Actively Recruiting
Risk Prediction Model for Iodinated Contrast Medium Extravasation
Led by Zhang Wenyan · Updated on 2025-03-05
1000
Participants Needed
1
Research Sites
96 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to develop a risk prediction model for iodine contrast agent extravasation from peripheral veins and to implement this model clinically to establish a risk control management system for iodine contrast agent extravasation.A case-control study design was employed to collect data for model development. The case group comprised patients who experienced iodine contrast agent extravasation during enhanced CT examinations, while the control group included patients who underwent similar examinations without extravasation.
CONDITIONS
Official Title
Risk Prediction Model for Iodinated Contrast Medium Extravasation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Volunteer to participate in this study.
- No contraindications such as iodine contrast allergy or hyperthyroidism.
You will not qualify if you...
- Communication barriers between researchers and patients.
- Critical condition or unstable vital signs requiring immediate transfer to clinical departments after examination.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
TongjiHospital
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
W
Wenyan Zhang, Master
CONTACT
Q
Qin Li
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here